Evidence map›Paper›PMID 37294512›Full record

SynthesisCurrent diabetes reports2023

Variations in the Design and Use of Attention Control Groups in Type 2 Diabetes Randomized Controlled Trials: a Systematic Review.

Casey A Droske, Triniece N Pearson, Sharon J Velkovich, Hannah Cohn, Jacqueline M Kanoon, Arshiya A Baig, Valerie G Press

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Current diabetes reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Casey A DroskeSection of General Internal Medicine, Center for Chronic Disease Research and Policy, University of Chicago, 5841 S. Maryland Ave. MC 2007B, Chicago, IL, 60637, USA. cdroske@bsd.uchicago.edu.
Triniece N PearsonDepartment of Medicine, University of Chicago, 900 E. 57th St. #8144, Chicago, IL, 60637, USA.
Sharon J VelkovichDepartment of Medicine, University of Chicago, 900 E. 57th St. #8144, Chicago, IL, 60637, USA.
Hannah CohnDepartment of Obstetrics and Gynecology, University of Chicago, 5841 S. Maryland Ave. MC 2050, Chicago, IL, 60637, USA.
Jacqueline M KanoonSection of General Internal Medicine, Center for Chronic Disease Research and Policy, University of Chicago, 5841 S. Maryland Ave. MC 2007B, Chicago, IL, 60637, USA.
Arshiya A BaigDepartment of Medicine, University of Chicago, 5841 S. Maryland Ave., Chicago, IL, 60637, USA.
Valerie G PressDepartments of Medicine and Pediatrics, University of Chicago, 5841 S Maryland Ave, MC 2007, Chicago, Illinois, 60637, USA.

Funding

Research Design, Data, and Analytics CoreP30DK092949 · NIDDK · UNIVERSITY OF CHICAGO · PI MILDA Renne SAUNDERS · 2011 to 2026
$10.0M
My Diabetes My CommunityR01DK127961 · NIDDK · UNIVERSITY OF CHICAGO · PI HUANG, ELBERT S., LINDAU, STACY TESSLER · 2020 to 2020
$5.4M
Research and Mentorship in Medical Decision Making for Chronic Diseases of Older AdultsK24AG069080 · NIA · UNIVERSITY OF CHICAGO · PI HUANG, ELBERT S. · 2020 to 2024
$583k
NIA NIH HHS K24 AG069080NIDDK NIH HHS 5P30DK092949NIDDK NIH HHS P30 DK092949NIDDK NIH HHS R01 DK127961NIDDK NIH HHS R01DK127961
6 · The paper itself

Abstract

purpose of reviewIn type 2 diabetes (T2D) research, the phrase "attention control group" (ACGs) has been used with varying descriptions. We aimed to systematically review the variations in the design and use of ACGs for T2D studies. RECENT

findingsTwenty studies utilizing ACGs were included in the final evaluation. Control group activities had the potential to influence the primary outcome of the study in 13 of the 20 articles. Prevention of contamination across groups was not mentioned in 45% of the articles. Eighty-five percent of articles met or somewhat met the criteria for having comparable activities between the ACG and intervention arms. Wide variations in descriptions and the lack of standardization have led to an inaccurate use of the phrase "ACGs" when describing the control arm of trials, indicating a need for future research with focus on the adoption of uniform guidelines for use of ACGs in T2D RCTs.

Indexed as

Diabetes Mellitus, Type 2Control GroupsHumansRandomized Controlled Trials as TopicAttention control groupBehavioral interventionRandomized controlled-trialType 2 diabetes

Identifiers

PMID37294512
PMCPMC10527690

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.